Laparoscopy versus laparotomy for the management of early stage endometrial cancer
K Galaal, H Donkers, A Bryant… - Cochrane Database of …, 2018 - cochranelibrary.com
Laparoscopy versus laparotomy for the management of early stage endometrial cancer -
Galaal, K - 2018 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve …
Galaal, K - 2018 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve …
[HTML][HTML] Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents
GC de Oliveira Santos, CC Vasconcelos… - Frontiers in …, 2018 - frontiersin.org
The Candida genus comprises opportunistic fungi that can become pathogenic when the
immune system of the host fails. Candida albicans is the most important and prevalent …
immune system of the host fails. Candida albicans is the most important and prevalent …
Surgical cytoreduction for recurrent epithelial ovarian cancer
T Al Rawahi, AD Lopes, RE Bristow… - Cochrane Database …, 2013 - cochranelibrary.com
Background The standard management of primary ovarian cancer is optimal cytoreductive
surgery followed by platinum‐based chemotherapy. Most women with primary ovarian …
surgery followed by platinum‐based chemotherapy. Most women with primary ovarian …
[HTML][HTML] Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Background Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5
years. We designed this trial to establish the effect of early detection by screening on ovarian …
years. We designed this trial to establish the effect of early detection by screening on ovarian …
[HTML][HTML] Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence …
U Menon, A Gentry-Maharaj, R Hallett, A Ryan… - The lancet …, 2009 - thelancet.com
Background Ovarian cancer has a high case–fatality ratio, with most women not diagnosed
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …
[HTML][HTML] Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
I Jacobs, A Gentry-Maharaj, M Burnell… - The lancet …, 2011 - thelancet.com
Background The increase in the worldwide incidence of endometrial cancer relates to rising
obesity, falling fertility, and the ageing of the population. Transvaginal ultrasound (TVS) is a …
obesity, falling fertility, and the ageing of the population. Transvaginal ultrasound (TVS) is a …
[HTML][HTML] Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United …
U Menon, A Ryan, J Kalsi… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected
Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of …
Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of …
Interventions for reducing anxiety in women undergoing colposcopy
K Galaal, K Deane, S Sangal… - Cochrane Database of …, 2007 - cochranelibrary.com
Background Before cervical cancer develops the cells of the cervix become abnormal.
Following an abnormal cervical smear colposcopy is performed. Colposcopy is the …
Following an abnormal cervical smear colposcopy is performed. Colposcopy is the …
[PDF][PDF] Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically …
RH Verheijen, L Massuger, BB Benigno, AA Epenetos… - 2006 - repository.ubn.ru.nl
PURPOSE: This was a multinational, open-label, randomized phase III trial comparing
yttrium-90-labeled murine HMFG1 (90Y-muHMFG1) plus standard treatment versus …
yttrium-90-labeled murine HMFG1 (90Y-muHMFG1) plus standard treatment versus …
Adjuvant chemotherapy for advanced endometrial cancer
K Galaal, M Al Moundhri, A Bryant… - Cochrane Database …, 2014 - cochranelibrary.com
Background Approximately 13% of women diagnosed with endometrial cancer present with
advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) …
advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) …